Lanean...
PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation
Immunotherapy has become a crucial modality for non-small-cell lung cancer treatment. Recently, two immune checkpoints, PD-1 and PD-L1, have emerged as important targets for immunotherapy. Their antitumor efficacy has been confirmed by in vitro and in vivo studies. But the correlation between PD-1/P...
Gorde:
| Argitaratua izan da: | J Transl Med |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4302082/ https://ncbi.nlm.nih.gov/pubmed/25592115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0373-0 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|